References
- An, P., Nelson, G.W., Wang, L., Donfield, S., Goedert, J.J., Phair, J., Vlahov, D., Buchbinder, S., Farrar, W.L., Modi, W., O'Brien, S.J., and Winkler, C.A. (2002). Modulating influence on HIV/AIDS by interacting RANTES gene variants. Proc. Natl. Acad. Sci. USA 99, 10002-10007. https://doi.org/10.1073/pnas.142313799
- Askew, Y.S., Pak, S.C., Luke, C.J., Askew, D.J., Cataltepe, S., Mills, D.R., Kato, H., Lehoczky, J., Dewar, K., Birren, B., and Silverman, G.A. (2001). SERPINB12 is a novel member of the human ov-serpin family that is widely expressed and inhibits trypsin-like serine proteinases. J. Biol. Chem. 276, 49320-19330. https://doi.org/10.1074/jbc.M108879200
- Bal, N., Kocer, N.E., Ertorer, M.E., Canpolat, E.T., and Kayaselcuk, F. (2008). Maspin, E-selectin, and P-selectin expressions in papillary thyroid carcinomas and their correlation with prognostic parameters. Pathol. Res. Pract. 204, 743-750. https://doi.org/10.1016/j.prp.2008.04.016
- Blandamura, S., Giacomelli, L., Leo, G., Segato, P., and Ninfo, V. (2006). Nuclear maspin detection in renal cell tumours: possible diagnostic role and correlation with p53 status. Histopathology 49, 274-282. https://doi.org/10.1111/j.1365-2559.2006.02504.x
- Cai, Z., Zhou, Y., Lei, T., Chiu, J.F., and He, Q.Y. (2009). Mammary serine protease inhibitor inhibits epithelial growth factor-induced epithelial-mesenchymal transition of esophageal carcinoma cells. Cancer 115, 36-48. https://doi.org/10.1002/cncr.23991
- Chun, J.Y., Park, B.L., Cheong, H.S., Kim, J.Y., Park, T.J., Lee, J.S., Lee, H.S., Kim Y.j., and Shin, H.D. (2009). Identification of polymorphisms in CYP2E1 gene and association analysis among chronic hbv patients. Genomics Inform. 7, 187-194. https://doi.org/10.5808/GI.2009.7.4.187
- Hall, D.C., Johnson-Pais, T.L., Grubbs, B., Bernal, R., Leach, R.J., and Padalecki, S.S. (2008). Maspin reduces prostate cancer metastasis to bone. Urol. Oncol. 26, 652-658. https://doi.org/10.1016/j.urolonc.2007.07.017
- Hedrick, P.W. (1987). Gametic disequilibrium measures: proceed with caution. Genetics 117, 331-341.
- Hong, S.N., Lee, J.K., Choe, W.H., Ha, H.Y., Park, K., Sung, I.K., Lee, K.T., Kim, J.J., and Rhee, J.C. (2009). The effect of aberrant maspin expression on the invasive ability of pancreatic ductal adenocarcinoma cells. Oncol. Rep. 21, 425-430.
- Kane, M.A. (1998). World-wide epidemiology of hepatitis B. Soz Praventivmed 43 Suppl 1:S24-26, S98-100. https://doi.org/10.1007/BF02042169
- Kashima, K., Ohike, N., Mukai, S., Sato, M., Takahashi, M., and Morohoshi, T. (2008). Expression of the tumor suppressor gene maspin and its significance in intraductal papillary mucinous neoplasms of the pancreas. Hepatobiliary Pancreat Dis. Int. 7, 86-90.
- Khalkhali-Ellis, Z. (2006). Maspin: the new frontier. Clin. Cancer Res. 12, 7279-7283. https://doi.org/10.1158/1078-0432.CCR-06-1589
- Kim, Y.J., Yoon, J.H., Kim, C.Y., Kim, L.H., Park, B.L., Shin, H.D., and Lee, H.S. (2006). IGF2 polymorphisms are associated with hepatitis B virus clearance and hepatocellular carcinoma. Biochem. Biophys. Res. Commun. 346, 38-44. https://doi.org/10.1016/j.bbrc.2006.05.080
- Koshy, R. (1998). Hepatitis B Virus. Imperial College Press, London.
- Kumar, V.F.N. (2003). Robbins & Cotran Pathologic Basis of Disease. Saunders.
- Lee, M.S., Kim, D.H., Kim, H., Lee, H.S., Kim, C.Y., Park, T.S., Yoo, K.Y., Park, B.J., and Ahn, Y.O. (1998). Hepatitis B vaccination and reduced risk of primary liver cancer among male adults: a cohort study in Korea. Int. J. Epidemiol. 27, 316-319. https://doi.org/10.1093/ije/27.2.316
- Lin, C.L., and Kao, J.H. (2008). Hepatitis B viral factors and clinical outcomes of chronic hepatitis B. J. Biomed. Sci. 15, 137-145. https://doi.org/10.1007/s11373-007-9225-8
- Maass, N., Hojo, T., Ueding, M., Luttges, J., Kloppel, G., Jonat, W., and Nagasaki, K. (2001). Expression of the tumor suppressor gene Maspin in human pancreatic cancers. Clin. Cancer Res. 7, 812-817.
- Menashe, I., Rosenberg, P.S., and Chen, B.E. (2008). PGA: power calculator for case-control genetic association analyses. BMC Genet. 9, 36.
- Oh, A.R., Lee, S.K., Kim, M.H., Cheong, J.Y., Cho, S.W., Yang, K.S., and Kwack, K.B. (2008). Polymorphisms in RAS guanyl-releasing protein 3 are associated with chronic liver disease and hepatocellular carcinoma in a Korean population. Genomics Inform. 6, 181-191. https://doi.org/10.5808/GI.2008.6.4.181
- Park, B.L., Kim, Y.J., Cheong, H.S., Kim, L.H., Choi, Y.H., Lee, H.S., and Shin, H.D. (2006). Association of common promoter polymorphisms of MCP1 with hepatitis B virus clearance. Exp. Mol. Med. 38, 694-702. https://doi.org/10.1038/emm.2006.82
- Park, B.L., Kim, Y.J., Cheong, H.S., Lee, S.O., Han, C.S., Yoon, J.H., Park, J.H., Chang, H.S., Park, C.S., Lee, H.S., and Shin, H.D. (2007). HDAC10 promoter polymorphism associated with development of HCC among chronic HBV patients. Biochem. Biophys. Res. Commun. 363, 776-781. https://doi.org/10.1016/j.bbrc.2007.09.026
- Sager, R., Sheng, S., Pemberton, P., and Hendrix, M.J. (1997). Maspin. A tumor suppressing serpin. Adv. Exp. Med. Biol. 425, 77-88. https://doi.org/10.1007/978-1-4615-5391-5_8
- Shao, L.J., Shi, H.Y., Ayala, G., Rowley, D., and Zhang, M. (2008). Haploinsufficiency of the maspin tumor suppressor gene leads to hyperplastic lesions in prostate. Cancer Res. 68, 5143-5151. https://doi.org/10.1158/0008-5472.CAN-08-0163
- Shin, H.D., Park, B.L., Cheong, H.S., Yoon, J.H., Kim, Y.J., and Lee, H.S. (2007). SPP1 polymorphisms associated with HBV clearance and HCC occurrence. Int. J. Epidemiol. 36, 1001-1008. https://doi.org/10.1093/ije/dym093
- Shin, H.D., Park, B.L., Kim, L.H., Jung, J.H., Kim, J.Y., Yoon, J.H., Kim, Y.J., and Lee, H.S. (2003). Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma. Hum. Mol. Genet. 12, 901-906. https://doi.org/10.1093/hmg/ddg104
- Stephens, M., Smith, N.J., and Donnelly, P. (2001). A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68, 978-989. https://doi.org/10.1086/319501
- Vildozola Gonzales, H., and Salinas, J.L. (2009). Natural history of chronic hepatitis B virus infection. Rev. Gastroenterol Peru 29, 147-157.